Detalhe da pesquisa
1.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094839
2.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875144
3.
Salvage Cryoablation for Local Recurrences of Thyroid Cancer Inseparable from the Trachea and Neurovascular Structures.
J Vasc Interv Radiol
; 34(1): 54-62, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36220608
4.
Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer.
Eur Thyroid J
; 13(1)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096102
5.
Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction.
Cell Genom
; 3(10): 100409, 2023 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37868034
6.
Accuracy and Reliability of Chatbot Responses to Physician Questions.
JAMA Netw Open
; 6(10): e2336483, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37782499
7.
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors.
Clin Cancer Res
; 28(22): 4871-4884, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044531
8.
Guiding immunotherapy combinations: Who gets what?
Adv Drug Deliv Rev
; 178: 113962, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481029
9.
Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab.
Immunotherapy
; 8(10): 1163-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605066